183 related articles for article (PubMed ID: 1545522)
1. [Current situation and problems in the estimation of circulating immune complexes].
Yoshida H
Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
[TBL] [Abstract][Full Text] [Related]
2. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
3. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
4. Characterization of circulating immune complexes detected by monoclonal rheumatoid factor and conglutinin radioimmunoassays in SLE nephritis.
Nishida SK; Alves MA; Ramos OL; Pereira AB
J Clin Lab Immunol; 1988 Dec; 27(4):163-9. PubMed ID: 3251047
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
6. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
8. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
9. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
10. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
13. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
14. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
15. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
Scullion M; Balint G; Whaley K
J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
[TBL] [Abstract][Full Text] [Related]
17. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
18. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
[TBL] [Abstract][Full Text] [Related]
19. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
Starkebaum G; Arend WP; Nardella FA; Gavin SE
J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes containing IgG, IgA and IgM in patients with myocardial infarction: detection with C1qSP and anti C3SP.
Triolo G; Traina M; Giardina E; Galluzzo A; Rinaldi A; Raineri A
J Clin Lab Immunol; 1984 Jan; 13(1):35-9. PubMed ID: 6609236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
